Users report improvements in digestive symptoms, reduced bloating, and better nutrient absorption
It's easier to use than growth hormone peptides, more targeted than comprehensive hormone optimization, and more effective than traditional fat burners
It may prove beneficial in acute or chronic wound and pain management
Skin improvements from GHK-Cu tend to develop more gradually, with noticeable changes in firmness and texture typically appearing around weeks 4 to 8
AOD 9604 is a modified fragment of the human growth hormone molecule, specifically the amino acids 176 to 191 at its tail end
local anesthetic applied Injection Points: Typically include the AC joint capsule and coracoclavicular ligament attachments Solution Used: 15-25% dextrose + 1% lidocaine or procaine Guidance: Can be done freehand or under ultrasound guidance for precision Post-Injection Care Mild soreness or swelling is expected for 13 days Avoid anti-inflammatory medications (they may blunt the desired response) Gentle range of motion exercises encouraged Physical therapy may be added at any time Treatment Frequency Prolotherapy is typically performed every 34 weeks 36 sessions are usually recommended depending on severity and how you are progressing Clinical Evidence Supporting Prolotherapy for AC Joint Injury While large randomized controlled trials are limited for AC separation specifically, prolotherapy has demonstrated efficacy in multiple musculoskeletal conditions involving ligament and joint instability: Rabago et al
